Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

Survey reveals severe impact of Good Days underfunding on retina practices, with many patients experiencing vision loss due ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

New findings confirm TearCare's long-term effectiveness for dry eye disease, showing significant patient improvements with ...

In a press release, the National Institute for Health and Care Excellence announced the first-ever approval for a ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

An intravitreal implant shows promise in enhancing visual function and retinal structure in diabetic retinopathy patients, ...

Nicox and Kowa entered into an agreemen in February 2024, in which Kowa was granted exclusive Japanese rights to develop and ...

FDA approval was based on data from phase 3 trials showing significant tear production increase as early as day 1.

TearCare is associated with greater health utility over time but also resulted in significant cost savings compared with CsA ...

Ophthalmology celebrates 50 years of groundbreaking innovations, highlighting anti-VEGF therapies, OCT imaging, and future ...

Genentech's Portal study shows Susvimo maintains vision and retinal drying in wet AMD patients over five years with biannual ...